Idiopathic pulmonary arterial hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
776
|
24
|
0.350 |
None |
1.000 |
6 |
|
2010 |
2019 |
Substance Withdrawal Syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
80
|
5
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug Withdrawal Symptoms
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Sign or Symptom
|
58
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cocaine Abuse
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
144
|
3
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cocaine-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
121
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Idiopathic pulmonary hypertension
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
161
|
5
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Withdrawal Symptoms
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Sign or Symptom
|
126
|
10
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cocaine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
199
|
39
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Pulmonary Hypertension
|
phenotype |
Respiratory Tract Diseases
|
Pathologic Function
|
156
|
|
0.200 |
None |
1.000 |
2 |
|
2007 |
2008 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.200 |
None |
1.000 |
1 |
|
2006 |
2006 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Male infertility
|
phenotype |
Male Urogenital Diseases
|
Disease or Syndrome
|
516
|
146
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.080 |
None |
1.000 |
8 |
|
2007 |
2019 |
Diabetic Nephropathy
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
1189
|
238
|
0.070 |
None |
1.000 |
7 |
|
2004 |
2018 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.060 |
None |
1.000 |
6 |
|
2009 |
2019 |
Fibrodysplasia Ossificans Progressiva
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
58
|
17
|
0.050 |
None |
1.000 |
5 |
1
|
2009 |
2018 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.050 |
None |
0.800 |
5 |
|
2007 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.050 |
None |
0.800 |
5 |
|
2007 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2012 |
2018 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1043
|
127
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2017 |